Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test - PubMed (original) (raw)
Meta-Analysis
Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test
M R Nieuwenstein et al. J Psychiatr Res. 2001 Mar-Apr.
Abstract
Cognitive deficits have been hypothesized to be differentially related to the negative, positive and disorganization dimensions of schizophrenia symptoms. In this article, we quantitatively review the published literature on the relationships between symptom dimensions in schizophrenia and performance on the two most widely applied tests of executive functioning and sustained attention, the Wisconsin Card Sorting Test (WCST) and the Continuous Performance Test (CPT). Meta-analyses were conducted on studies that reported correlational data for the relations between performance on these tests and scales of positive and negative symptoms. The more recent distinction between disorganization and reality distortion was also taken into account. The results showed statistically significant relationships of negative symptoms with worse performance on the WCST and the CPT. Disorganization symptoms showed a significant positive correlation with perseverations on the WCST, but not with CPT performance. In contrast, reality distortion symptoms and general scores for all positive symptoms did not correlate with either measure. Although some correlations were statistically significant, the observed associations between psychiatric symptoms and cognitive performance were typically weak, suggesting relative independence of these disease processes.
Similar articles
- Schizophrenic syndrome and Wisconsin Card Sorting Test dimensions.
Cuesta MJ, Peralta V, Caro F, de Leon J. Cuesta MJ, et al. Psychiatry Res. 1995 Sep 8;58(1):45-51. doi: 10.1016/0165-1781(95)02649-h. Psychiatry Res. 1995. PMID: 8539311 - Clinical symptom dimensions and deficits on the Continuous Performance Test in schizophrenia.
Liu SK, Hwu HG, Chen WJ. Liu SK, et al. Schizophr Res. 1997 Jun 20;25(3):211-9. doi: 10.1016/s0920-9964(97)00026-1. Schizophr Res. 1997. PMID: 9264176 - Card-sort performance and syndromes of schizophrenia.
Rowe EW, Shean G. Rowe EW, et al. Genet Soc Gen Psychol Monogr. 1997 May;123(2):197-209. Genet Soc Gen Psychol Monogr. 1997. PMID: 9204545 - Can specific deficits in executive functioning explain the negative symptoms of schizophrenia? A review.
Donohoe G, Robertson IH. Donohoe G, et al. Neurocase. 2003 Apr;9(2):97-108. doi: 10.1076/neur.9.2.97.15075. Neurocase. 2003. PMID: 12925934 Review.
Cited by
- Deficient maturation of aspects of attention and executive functions in early onset schizophrenia.
Jepsen JR, Fagerlund B, Pagsberg AK, Christensen AM, Nordentoft M, Mortensen EL. Jepsen JR, et al. Eur Child Adolesc Psychiatry. 2010 Oct;19(10):773-86. doi: 10.1007/s00787-010-0126-4. Epub 2010 Aug 1. Eur Child Adolesc Psychiatry. 2010. PMID: 20680364 - Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia.
Chudasama Y, Robbins TW. Chudasama Y, et al. Psychopharmacology (Berl). 2004 Jun;174(1):86-98. doi: 10.1007/s00213-004-1805-y. Epub 2004 Apr 8. Psychopharmacology (Berl). 2004. PMID: 15071717 Review. - Negative symptoms and concomitant attention deficits in schizophrenia: associations with prospective assessments of anxiety, social dysfunction, and avoidant coping.
Tsai J, Lysaker PH, Vohs JL. Tsai J, et al. J Ment Health. 2010 Apr;19(2):184-92. doi: 10.3109/09638230903469277. J Ment Health. 2010. PMID: 20433326 Free PMC article. Clinical Trial. - Directed forgetting in schizophrenia: prefrontal memory and inhibition deficits.
Müller U, Ullsperger M, Hammerstein E, Sachweh S, Becker T. Müller U, et al. Eur Arch Psychiatry Clin Neurosci. 2005 Aug;255(4):251-7. doi: 10.1007/s00406-004-0554-6. Epub 2004 Nov 22. Eur Arch Psychiatry Clin Neurosci. 2005. PMID: 16133743 Clinical Trial. - Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review.
Wilson N, Cadet JL. Wilson N, et al. J Addict Dis. 2009 Oct;28(4):309-19. doi: 10.1080/10550880903182960. J Addict Dis. 2009. PMID: 20155601 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical